Curium’s Phase 3 ECLIPSE Trial Starts Enrolling Patients
May 03, 2022 01:05 ET
|
Curium
ST. LOUIS, May 03, 2022 (GLOBE NEWSWIRE) -- Curium announced today it has successfully enrolled and dosed patients in the ECLIPSE Trial. ECLIPSE is a Phase 3, multi-center, open-label, randomized...
Curium Announces Significant Increase in Detectnet™ (copper Cu 64 dotatate injection) Production Capacity
April 19, 2022 01:00 ET
|
Curium
ST. LOUIS, April 19, 2022 (GLOBE NEWSWIRE) -- Curium announced today that it will be increasing production capacity of Detectnet to accommodate the significant demand in the market. Curium will now...
Curium Announces FDA Approval of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.
April 05, 2022 01:05 ET
|
Curium
ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) -- Curium announced today that its generic version of DaTscan (Ioflupane I 123 Injection) was approved on March 30, 2022, by the U.S. Food and Drug...
Monopar Announces Clinical and Preclinical Program Updates
February 15, 2022 08:05 ET
|
Monopar Therapeutics Inc.
Validive Phase 2b/3 VOICE trial now open at 43 sites; active and enrolling in US and EU Open-label Phase 1b camsirubicin trial: early signs of clinical benefit observed WILMETTE, Ill., Feb. 15,...
Global Radiopharmaceuticals Market Analysis Report 2021: Market to Reach $8.9 Billion by 2026 - COVID-19 Presents Generational Opportunity
January 27, 2022 04:43 ET
|
Research and Markets
Dublin, Jan. 27, 2022 (GLOBE NEWSWIRE) -- The "Radiopharmaceuticals - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
Curium to become major player in the supply on non carrier added Lu-177
January 25, 2022 00:00 ET
|
Curium
London, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Today Curium has announced a technology license agreement granting access to ECZACIBAŞI MONROL NÜKLEER ÜRÜNLER SANAYİ VE TİCARET A.Ş non carrier added...
Curium to become major player in the supply on non carrier added Lu-177
January 25, 2022 00:00 ET
|
Curium
LONDON, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Today Curium has announced a technology license agreement granting access to ECZACIBAŞI MONROL NÜKLEER ÜRÜNLER SANAYİ VE TİCARET A.Ş non carrier added...
Eckert & Ziegler’s GalliaPharm® distributed by Curium in France
March 01, 2021 19:15 ET
|
Curium
Berlin, Germany and Paris, France, March 01, 2021 (GLOBE NEWSWIRE) -- Eckert & Ziegler Radiopharma GmbH and Curium PET France have decided to reinforce their existing long term partnership by...